AUS
NZ
UK
CA
USA
IND
Healthcare
GENinCode Partners with Genesupport to Expand Access to ROCA® Test in Switzerland
December 10, 2024 07:59 AM GMT| By Team Kalkine MediaHighlights,GENinCode partners with Genesupport SA to expand ROCA® Test availability across Switzerland.,The ROCA Test, recommended by NICE in March 2024, is designed for women at high risk of ovarian cancer.,The collaboration will support over 11,000...
.jpg)
Faron Pharmaceuticals Ltd. (AIM: FARN) Announces Positive Phase 2 Results for BEXMAB in Refractory or Relapsed MDS
December 10, 2024 07:41 AM GMT| By Team Kalkine MediaHighlights,80% overall response rate (16 out of 20) in refractory/relapsed MDS patient population.,70% of patients achieved complete/partial response, with four progressing to bone marrow transplant.,Webinar scheduled for today to discuss promising B...
EMV Capital Celebrates £1 Million Fundraising for Wanda Connected Health Systems
December 09, 2024 10:47 AM GMT| By Team Kalkine MediaHighlights,EMV Capital increases its stake in Wanda Connected Health Systems to 21.9%, now valued at £1.35 million.,Wanda secures £1 million to enhance AI algorithms, expand in the US, and seek regulatory approvals.,New partnerships, including with t...
Poolbeg Pharma Showcases Promising Pre-Clinical Results for POLB 001 in Combatting CRS
December 09, 2024 10:47 AM GMT| By Team Kalkine MediaHighlights,POLB 001 demonstrates significant reduction in Cytokine Release Syndrome (CRS) symptoms in pre-clinical studies.,The therapy outperforms Adalimumab, a standard treatment, in reducing key inflammatory markers.,Pre-clinical findings position...
ValiRx Announces Discounted Share Offering to Fund R&D Initiatives
December 09, 2024 10:27 AM GMT| By Team Kalkine MediaHighlights,ValiRx plans to raise £1.57 million through a discounted share offering priced at 0.65p per share.,Funds will support preclinical testing, cancer therapy expansion, and new evaluation projects.,Shares fell 46% in early trading, reflecting...
_08_14_2024_19_46_34_162002.jpg)
PureTech Health (LSE: PRTC) Presents Promising Phase 1b Data for LYT-200 in AML and MDS at ASH 2024
December 09, 2024 07:22 AM GMT| By Team Kalkine MediaHighlights,PureTech unveils favorable Phase 1b data for LYT-200 in relapsed/refractory AML and MDS.,LYT-200 shows clinical benefit, safety, and sustained disease management in heavily pre-treated patients.,Positive results highlight LYT-200’s potenti...
Smith & Nephew Insider Transaction
December 06, 2024 11:44 AM GMT| By Team Kalkine MediaHighlights,Smith & Nephew (LON:SN) insider Deepak Nath sold 34,033 shares on December 5th.,The company’s stock opened at GBX 978.80 on Friday, with a market cap of £8.53 billion.,Smith & Nephew continues to show solid performance with a PE ratio of 3...
Frasers Group Announces Voluntary Offer for XXL Shares Amid Financial Challenges
December 06, 2024 11:06 AM GMT| By Team Kalkine MediaHighlights,Frasers Group proposes a voluntary offer of 10 NOK per share, valuing XXL at NOK 246.36 million.,The offer represents a 25% premium to XXL’s closing share price on 5 December.,Frasers plans measures to address XXL’s liquidity issues and su...
Eli Lilly Announces $3 Billion Manufacturing Expansion in Wisconsin
December 06, 2024 11:06 AM GMT| By Team Kalkine MediaHighlights,Eli Lilly commits $3 billion to expand its manufacturing plant in Kenosha County, Wisconsin.,Expansion will create 750 high-skilled jobs and over 2,000 construction roles.,Facility to focus on producing injectable medicines, including trea...
Camellia Plc (LON:CAM) Shareholder Structure Private Companies Lead the Way
December 06, 2024 08:49 AM GMT| By Team Kalkine MediaHighlights:,Private companies dominate,Private entities hold 52% of Camellia Plc (LON:CAM), giving them significant influence over its direction.,Institutional interest,Institutions own 35%, reflecting substantial professional analysis and interest i...
Hemogenyx Pharmaceuticals Achieves Breakthrough in Chimeric Bait Receptor Delivery
December 06, 2024 08:36 AM GMT| By Team Kalkine MediaHighlights,Hemogenyx develops a novel method to deliver Chimeric Bait Receptors (CBR) to immune cells using lentiviral vectors.,The breakthrough enhances macrophage and monocyte efficacy, key components of the immune system.,This advancement accelera...
Spire Healthcare Group (LON:SPI) Increasing Returns Signal Growing Efficiency
December 06, 2024 07:28 AM GMT| By Team Kalkine MediaHighlights,Improved ROCE performance,Spire Healthcare Group's return on capital employed (ROCE) has risen by 50% over five years.,Steady capital utilization,Higher returns have been achieved without significant changes in capital employed.,Strong mar...
INSPECS Group (LON:SPEC) Shares Rise 1% Amid Decline in Trading Volume
December 05, 2024 11:32 AM GMT| By Team Kalkine MediaHighlights,Share Price Movement,INSPECS Group's stock rose by 1% during mid-day trading on Wednesday, closing at GBX 50.,Trading Activity,Trading volume dropped 43% below the average, with 163,147 shares traded compared to 284,611.,Key Metrics,The co...
Faron Pharmaceuticals Oy (LON:FARN) Posts Modest Stock Gains Amid Low Trading Volume
December 05, 2024 11:28 AM GMT| By Team Kalkine MediaHighlights,Stock Performance,Faron Pharmaceuticals Oy (FARN) shares rose by 1.3%, reaching a high of GBX 200 before closing at GBX 195.,Volume Decline,Trading activity dropped significantly, with only 6,878 shares traded, an 85% decrease from the ave...
Scancell Holdings plc (LON:SCLP) Faces 22.7% Decline Amid Increased Trading Activity
December 05, 2024 11:12 AM GMT| By Team Kalkine MediaHighlights,Scancell Holdings plc (SCLP) drops by 22.7% during Thursday’s trading session.,Trading volume surged to 1,612,554 shares, up by 135%.,Stock price dropped to GBX 10.44, down from the previous close of GBX 13.50.,Scancell Holdings plc (LON:S...
Scancell Holdings PLC (LSE:SCLP) Secures Transformative Partnerships with Genmab
December 04, 2024 02:50 PM GMT| By Team Kalkine MediaHighlights,Scancell Holdings partners with Genmab in agreements worth up to $1.2 billion.,The partnerships focus on advancing immuno-oncology therapies.,Collaboration bolsters Scancell’s journey from research to clinical and commercial stages.,For ju...
Smith & Nephew PLC (LSE:SN): Positioned for Recovery Amid Medtech Sector Challenges
December 03, 2024 02:42 PM GMT| By Team Kalkine MediaHighlights,JP Morgan reiterates 'overweight' stance on Smith & Nephew, citing undervaluation and recovery potential.,European medtech sector faces ongoing challenges, including slower market growth and geopolitical pressures.,Smith & Nephew stands ou...
EMV Capital Plans £1.5 Million Fundraising to Strengthen Global Deep-Tech and Life Sciences Portfolio
December 03, 2024 01:08 PM GMT| By Team Kalkine MediaHighlights:,£1.5 Million Fundraising Announced:,EMV Capital aims to raise funds through a subscription and retail offer priced at a 15% premium over the last closing price.,Focus on Growth and Operational Efficiency:,Proceeds will support portfolio e...
GSK Shareholders Face Losses as Stock Struggles Over the Long Term
December 03, 2024 12:52 PM GMT| By Team Kalkine MediaHighlights,GSK stock down 38% over the past five years.,The company’s earnings per share (EPS) declined by 12% annually during this period.,Total shareholder return (TSR) over five years is -3.4%, with dividends partly offsetting the loss.,GSK’s Stru...
_06_30_2023_09_48_49_431348.jpg)
SEED Innovations Rewards Shareholders in Latest Half, Delivers Strong Portfolio Performance
December 03, 2024 11:24 AM GMT| By Team Kalkine MediaHighlights,SEED Innovations delivered significant shareholder value through a £0.2 million share buyback and a £2 million special dividend.,The investment company realized a 35% gain on a post-period divestment, showcasing its effective short-term tr...
